Literature DB >> 17459283

Effects of ossicular prosthesis mass and section of the stapes tendon on middle ear transmission.

Manohar Bance1, David P Morris, Rene Van Wijhe.   

Abstract

BACKGROUND: The effects of changing prosthesis mass on middle ear transmission have not been previously systematically studied. Neither has the effect of stapes tendon sectioning. These are important parameters that can be surgically varied. HYPOTHESIS: Because the middle ear is compliance dominated at low frequencies, prosthesis mass will affect transmission of higher frequencies in the middle ear.
METHODS: Eight fresh cadaveric temporal bones, with the incus removed, were loaded with a replacement prosthesis from the tympanic membrane to the stapes head. Laser Doppler vibrometry was used to measure stapes footplate vibrations. Vibrations were measured in response to chirps from 250 to 8 kHz at 90 dB SPL in the ear canal. The unloaded prosthesis mass was approximately 16 mg. Loadings with masses of approximately 2, 12, and 30 mg were placed on the stem. Recordings were repeated after cutting the stapes tendon.
RESULTS: Mass loading affected the higher frequencies only, with significant effects only above 4 kHz. There was little low-frequency effect. Stapes tendon section showed an improvement in the lower frequencies but did not reach statistical significance.
CONCLUSIONS: Mass of prostheses affects mainly higher frequencies. There is no drop in lower frequencies from using lower masses, so lighter-mass prostheses may be preferred. Stapes tendon section does not have a detrimental effect on middle ear transmission after ossiculoplasty.

Entities:  

Mesh:

Year:  2007        PMID: 17459283     DOI: 10.2310/7070.2007.0008

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  1 in total

1.  Laser Doppler vibrometry measurements of human cadaveric tympanic membrane vibration.

Authors:  Jason A Beyea; Seyed Alireza Rohani; Hanif M Ladak; Sumit K Agrawal
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.